We are delighted to announce that we have secured $6.5 million of funding from the Bill & Melinda Gates Foundation to develop breath-based diagnostics for infectious diseases. Breath contains many potentially informative compounds that can be used for infectious disease diagnosis and monitoring, and the collection of breath has many unique advantages. Exhaled breath can be collected completely non-invasively and can be developed into portable devices that are easy to use. Through this partnership, we aim to identify non-invasive breath biomarkers of key diseases that disproportionately affect the developing world. We will then use this knowledge to build low-cost devices that can be used to reduce the burden of illness in resource-constrained environments. We are so thankful for the opportunity and are excited to get going with this project and work towards our mission of saving 100,000 lives! https://ow.ly/f9a750RmYvz
Owlstone Medical
Research
Cambridge, England 15,434 followers
On a mission to save 100k lives and $1.5B healthcare costs
About us
Owlstone Medical is developing a breathalyzer for disease. With a goal of finding ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health, and other conditions. Our mission is to save 100,000 lives and $1.5B in healthcare costs by advancing early detection and precision medicine. Breath Biopsy® aims to develop a new diagnostic modality making it possible to discover novel non-invasive biomarkers in breath using a platform with the potential to transition to point-of-care. The award-winning ReCIVA® Breath Sampler ensures the reliable collection of breath samples. The volatile organic compounds (VOCs) present in breath are analyzed using state-of-the-art chemical analysis technologies. Our aim is to develop tools, potentially based on our proven microchip chemical sensor technology (FAIMS), to detect validated biomarkers of disease. The Breath Biopsy platform provides biomarker discovery and validation capabilities to support the development of applications in precision medicine for a wide range of other medical conditions. Highly sensitive and selective, our platform allows for early diagnosis when treatments are more effective and more lives can be saved. Owlstone Medical is involved in studies related to major and rapidly growing health concerns including lung cancer, asthma and liver disease. We are also participants in extensive partnerships focusing on multiple cancer types, pulmonary hypertension, mesothelioma, workplace exposures and much more. Our Breath Biopsy Products and Services are available to academic, clinical, and pharma research partners who want to develop breath-based diagnostics for their own applications. Our products and services are for research use only. Not for use in diagnostic procedures.
- Website
-
http://www.owlstonemedical.com
External link for Owlstone Medical
- Industry
- Research
- Company size
- 51-200 employees
- Headquarters
- Cambridge, England
- Type
- Privately Held
- Founded
- 2004
- Specialties
- medical devices, diagnostics, lung cancer, precision medicine, colon cancer, and companion diagnostics
Locations
-
Primary
Get directions
183 Cambridge Science Park
Cambridge, England, GB
Employees at Owlstone Medical
Updates
-
Owlstone Medical reposted this
From Launch to Award! Owlstone Medical x Douglass Digital Story🏆 We are delighted to announce that our client, Owlstone Medical, has won website of the year for their OMED Health website at the SME Cambridgeshire Business Awards! 🎉 Congratulations to Charlie Douglass, Caitlin Curran, Grace R., and Petya Ivanova, PhD, MRSC, who attended the awards and celebrated this amazing win!🎊 The OMED Health website was launched in February 2023 and continues to grow with ongoing SEO and content strategies and UX updates, all accomplished by the Owlstone Marketing team alongside our SEO expertise. 🤝📈 Well done, Team Owlstone Medical and Douglass Digital! 👏 Here’s to more wins together! 🌟 #AwardWinningWebsite #SMEAwards #WebsiteOfTheYear #DouglassDigital #OwlstoneMedical #SEO #Marketing #WebsiteOfTheYear
-
-
Our CEO Billy Boyle recently had an article published in the Clinical Services Journal on how breath analysis technology can support the treatment of gut health conditions. 🌐 In his article, Billy discusses the scale of gut health issues in the UK, how breath analysis is currently supporting the treatment of gut health conditions, as well as the future potential of breath tests. You can read Billy's article here: https://ow.ly/j5jG50TgfrV #guthealth #breathanalysis #technology
-
-
Did you know? We are developing a breath test capable of detecting liver disease early before any symptoms show, involving the use of an Exogenous Volatile Organic Compound (EVOC®) Probe known as limonene to probe the function of the liver. Learn more about this work via the video below, which includes details of our whitepaper summarizing the potential of breath analysis in liver disease research, what data we have, and how Owlstone Medical can aid your research: https://ow.ly/Ls5k50SSSjo
Untargeted Liver Paper video
https://www.youtube.com/
-
Have you seen our recent #1minchallenge videos? Today, Grace and Ash explain a little bit about what it's like to work in #Talent at Owlstone. Are you interested in joining the team? We have various opportunities open throughout the year and would love to hear from you. Find out more: https://ow.ly/reaW50SL57P #hiring #jobs #science
-
Our Breath Biopsy VOC Atlas® is an expanding reference database of the chemically identified, confirmed compounds in human breath 🌬️. 🌐 We are excited to share that a preview of our VOC Atlas will soon be accessible for public use. This will help researchers confidently identify VOCs in breath as well as improve standardization in the breath research field. Stay in the loop and gain access to our Atlas when its live by signing up to our waitlist here 🎉: https://ow.ly/7QWF50TcCiR #biomarker #voc #breathanalysis
-
-
Webinar On-Demand📢 Discover how to carry out breath analysis of the microbiome over time, affordably, and in the patient's own home throughout clinical trials through our latest webinar! Learn about the OMED Health Breath Analyzer, an innovative tool that provides immediate hydrogen and methane readings. Key insights include understanding hydrogen and methane in GI diseases, broader disease contexts, advanced OMED device technology, and expanding the On-Breath VOCs in the VOC Atlas. Don't miss out on these insights! Watch the webinar for free now: 🔗 https://ow.ly/V18B50SFbuN
Revolutionizing Home-Based Microbiome Analysis: On-Demand Webinar
https://www.owlstonemedical.com
-
As the summer comes to a close we would like to thank our interns for all the hard work they have put in over the past weeks and months. We wish you all the best of luck in continuing your studies! 👩🎓 For those of you interested in interning with us for the summer of 2025, please email us your CV at owlstone-medical@jobs.workablemail.com You can find our current opportunities via the link below: 🔍 https://ow.ly/grVv50SMXHr #internship #science #business #breathresearch #guthealth
-
-
Owlstone Medical reposted this
Gold Winner of the Website of the Year is OMED Health. Congratulations! #SMECAMBS
-